Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone

被引:159
|
作者
Seifer, DB
Scott, RT
Bergh, PA
Arbogast, LK
Friedman, CI
Mack, CK
Danforth, DR
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Univ Ctr Reprod Endocrinol & Fertil, Dept Obstet Gynecol & Reprod Sci, New Brunswick, NJ 08902 USA
[2] St Barnabas Med Ctr, Inst Reprod Med & Sci, Livingston, NJ USA
[3] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA
关键词
inhibin B; FSH; ovarian reserve;
D O I
10.1016/S0015-0282(99)00193-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To test the hypothesis that women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B levels before a rise in day 3 serum FSH levels. Design: Case-control study. Setting: Tertiary care fertility center. Patient(s): One hundred nine women with nonovarian infertility (tubal factor or male factor) and 37 women with declining ovarian reserve who underwent assisted reproductive techniques. Intervention(s): None. Main Outcome Measure(s): Serum inhibin B and FSH levels, number of ampules of gonadotropins administered, E-2 levels on the day of hCG administration, number of oocytes retrieved, clinical pregnancy rate, and cycle cancellation rate. Result(s): Women who had declining ovarian reserve as demonstrated by an increased gonadotropin requirement, a decreased E-2 response, fewer retrieved oocytes, a lower clinical pregnancy rate, and a higher cycle cancellation rate had lower day 3 serum inhibin B levels despite having nonelevated day 3 FSK levels similar to those of women with nonovarian infertility. Conclusion(s): Women with declining ovarian responsiveness and clinical outcomes consistent with declining ovarian reserve had decreased day 3 serum inhibin B levels despite having nonelevated day 3 serum FSH concentrations. Declining ovarian reserve may be demonstrated by a decrease in day 3 inhibin B levels before a rise in day 3 FSH levels. (Fertil Steril(R) 1999;72:63-5. (C)1999 by American Society for Reproductive Medicine.).
引用
收藏
页码:63 / 65
页数:3
相关论文
共 50 条
  • [1] The value of day 3 follicle-stimulating hormone levels
    Harrison, RF
    FERTILITY AND STERILITY, 2000, 73 (02) : 420 - 421
  • [2] Value of the day 3 follicle-stimulating hormone measurement
    Wolff, EF
    Taylor, HS
    FERTILITY AND STERILITY, 2004, 81 (06) : 1486 - 1488
  • [3] Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status
    Fanchin, R
    Cunha, JS
    Schonäuer, LM
    Righini, C
    de Ziegler, D
    Frydman, R
    FERTILITY AND STERILITY, 2003, 79 (03) : 585 - 589
  • [4] Early follicle development alters the relationship between antral follicle counts and inhibin B and follicle-stimulating hormone levels on cycle day 3
    Grynberg, Michael
    Feyereisen, Estelle
    Scheffer, Juliano Brum
    Koutroubis, Panayotis
    Frydman, Rene
    Fanchin, Renato
    FERTILITY AND STERILITY, 2010, 93 (03) : 894 - 899
  • [5] Day 3 serum inhibin-B may be the earliest indication of diminished ovarian reserve in women undergoing ART.
    Seifer, DB
    Scott, RT
    Bergh, PA
    Arbogast, LK
    Friedman, CI
    Mack, CK
    Danforth, DR
    FERTILITY AND STERILITY, 1997, : O184 - O184
  • [6] Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy
    Nasseri, A
    Mukherjee, T
    Grifo, JA
    Noyes, N
    Krey, L
    Copperman, AB
    FERTILITY AND STERILITY, 1999, 71 (04) : 715 - 718
  • [7] Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome
    Scott, Richard T.
    Toner, James P.
    Muasher, Suheil J.
    Oehninger, Sergio
    Robinson, Shirley
    Rosenwaks, Zev
    FERTILITY AND STERILITY, 2019, 112 (04) : E174 - E177
  • [8] Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter, Irene
    Dimitriadis, Irene
    Baltagi, Lina M.
    Meeker, John D.
    Petrozza, John C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (01) : 62.e1 - 62.e8
  • [9] Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels
    Martin, JSB
    Nisker, JA
    Tummon, IS
    Daniel, SAJ
    Auckland, JL
    Feyles, V
    FERTILITY AND STERILITY, 1996, 65 (06) : 1238 - 1240
  • [10] Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank
    Irvin, Sarah R.
    Weiderpass, Elisabete
    Stanczyk, Frank Z.
    Brinton, Louise A.
    Trabert, Britton
    langseth, HilDe
    Wentzensen, Nicolas
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (03) : 636 - 642